Prescription drug · ANDA
Lamotrigine NDC 13668-049
Lamotrigine 200 mg/1 · Tablet · Oral · Torrent Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 13668-049-01 | 13668004901 | 100 TABLET in 1 BOTTLE (13668-049-01)Marketed from Jan 27, 2009 | |
| 13668-049-05 | 13668004905 | 500 TABLET in 1 BOTTLE (13668-049-05)Marketed from Jan 27, 2009 | |
| 13668-049-13 | 13668004913 | 1300 TABLET in 1 BOTTLE (13668-049-13)Marketed from Jan 27, 2009 | |
| 13668-049-30 | 13668004930 | 30 TABLET in 1 BOTTLE (13668-049-30)Marketed from Jan 27, 2009 | |
| 13668-049-60 | 13668004960 | 60 TABLET in 1 BOTTLE (13668-049-60)Marketed from Jan 27, 2009 | |
| 13668-049-64 | 13668004964 | 90 TABLET in 1 DOSE PACK (13668-049-64)Marketed from Jan 27, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lamotrigine
- Generic name (nonproprietary)
- lamotrigine
- Active ingredients
- Lamotrigine — 200 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078947
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)Dihydrofolate Reductase Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)
- Identifiers
- Product ID 13668-049_7f173ac5-3a79-4426-ae9b-7149427975abSPL ID 7f173ac5-3a79-4426-ae9b-7149427975abSPL set ID 3448839b-4933-4ef9-a80a-9e504d2c5696RxCUI 198427, 198428, 198429, 282401, 751139, 751563, 753451UNII U3H27498KSUPC 0313668048605, 0313668045017
- Pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N413668004901followed by a unit qualifier and the quantityPackage 13668-0049-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lamotrigine tablet is indicated for: Epilepsy—adjunctive therapy in patients aged 2 years and older: partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome. ( 1.1 ) Epilepsy—monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug. ( 1.1 ) Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy. ( 1.2 ) Limitations of Use…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 078947
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2755 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-855 |
| LAMOTRIGINE Kitlamotrigine | — | Kit | OWP Pharmaceuticals, Inc. | 69102-137 |
| Subvenitelamotrigine | — | Kit | OWP Pharmaceuticals, Inc. | 69102-306 |
| Subvenitelamotrigine | Lamotrigine 150 mg/1 | TabletOral | OWP Pharmaceuticals, Inc. | 69102-150 |
| Subvenitelamotrigine | — | Kit | OWP Pharmaceuticals, Inc. | 69102-300 |
| Subvenitelamotrigine | Lamotrigine 25 mg/1 | TabletOral | OWP Pharmaceuticals, Inc. | 69102-301 |
| LAMOTRIGINE Kitlamotrigine | — | Kit | OWP Pharmaceuticals, Inc. | 69102-359 |
| Subvenitelamotrigine | — | Kit | OWP Pharmaceuticals, Inc. | 69102-312 |
| Subvenitelamotrigine | Lamotrigine 100 mg/1 | TabletOral | OWP Pharmaceuticals, Inc. | 69102-319 |
| Subvenitelamotrigine | Lamotrigine 200 mg/1 | TabletOral | OWP Pharmaceuticals, Inc. | 69102-320 |
| Lamotrigine | Lamotrigine 150 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | 13668-048 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | 13668-045 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | 13668-047 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | OWP Pharmaceuticals, Inc. | 69102-639 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2889 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3607 |
| Lamotrigine | — | Kit | Torrent Pharmaceuticals Limited | 13668-266 |
| Lamotrigine | Lamotrigine 200 mg/1 | TabletOral | A-S Medication Solutions | 50090-6028 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-238 |
Showing 20 of 21.